Karachi: Abbott Laboratories (Pakistan) Limited has announced the schedule for its upcoming Annual General Meeting (AGM). The meeting is set to take place on April 23, 2025. The notice has been circulated among the Trading Right Entitlement (TRE) Certificate Holders of the Pakistan Stock Exchange.

The AGM will serve as a platform for Abbott Laboratories (Pakistan) Limited to engage with its shareholders and discuss the company’s performance over the past year. The meeting is part of the company’s regular governance activities, providing an opportunity for shareholders to review the financial statements, appoint auditors, and address any other matters as prescribed in the notice.

According to information available from the Pakistan Stock Exchange (PSX), the notice of the AGM, dated March 25, 2025, has been disseminated to ensure all TRE Certificate Holders are informed and can participate in the meeting. The designated market category for Abbott Laboratories (Pakistan) Limited is the pharmaceutical sector.

The company’s focus on maintaining transparency and communication with its shareholders is reflected in the timely distribution of the AGM notice. Shareholders are expected to attend the meeting, either in person or through proxies, to exercise their voting rights and contribute to the decision-making processes essential to the company’s governance and strategic direction.